From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Celadon: this CULS malarky smells all wrong, a £53m short!

By Tom Winnifrith | Tuesday 26 March 2024

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

I have been a bear of Celadon Pharmaceuticals (CEL) since last March when the shares were c 150p. My scepticism caused much consternation for its PR bird Sarah McLeod who called to complain bitterly that I had ruined some feminazi lunch she’d been attending with what she termed my “daily hit job.” Or put another way, an article she had not actually read. The shares are now 85p but something still does not stack up. I do hope there is no FemiNazi lunch planned for today…
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was



Anpario – a recovery Buy?...

Thursday »


Bearcast issue update: all should be well



Oracle Power: Cynical Foul

Time left: 04:22:58